Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Major report reveals problems with EU Clinical Trials Directive

This article was originally published in SRA

Executive Summary

The European Clinical Trials Directive, which came into force in 2004 with the goal of harmonising the clinical research environment throughout the European Union, has made it more complicated for sponsors to conduct multinational clinical trials. It has also increased the administrative burden for competent authorities evaluating and supervising clinical trial authorisations. These are just two of many findings from a major EU-sponsored project set up to examine how the directive (2001/20/EC) has affected pharmaceutical research in the EU1,2.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts